Key result
Positive results on contrast-enhanced dobutamine stress echocardiography independently predicted total cardiac events in both men (HR 2.15) and women (HR 1.77) and provided incremental prognostic information.
Why the study?
Gender differences in the predictors of outcome among patients with known or suspected CAD undergoing contrast-enhanced dobutamine stress echocardiography have not been completely determined.
Does contrast-enhanced dobutamine stress echocardiography provide incremental prognostic information for future cardiac events in both men and women with known or suspected CAD?
Cohort (n=890)
No
Does contrast-enhanced dobutamine stress echocardiography provide incremental prognostic information for future cardiac events in both men and women with known or suspected CAD?
Hazard Ratio: 2.15 (95% CI 1.48–3.13)
p-value: p=<0.0001
Contrast-enhanced dobutamine stress echocardiography provides incremental prognostic value over clinical and rest echocardiography models for predicting future cardiac events in both men and women with known or suspected CAD.
CE-DSE adds incremental prognostic value for total events in both sexes; leaves open whether gender-specific predictors should guide tailored risk models.
BACKGROUND: Gender differences in the predictors of outcome among patients with known or suspected coronary artery disease (CAD) undergoing contrast-enhanced dobutamine stress echocardiography (CE-DSE) have not been completely determined. METHODS AND RESULTS: Follow-up (30+/-17 months) data for 581 men and 309 women with known or suspected CAD who underwent CE-DSE (mean age: 66 years) were obtained. Hard cardiac events included cardiac death and nonfatal myocardial infarction. Total cardiac events included hard cardiac events, unstable angina, congestive heart failure, and late revascularization (>3 months). Cardiac events occurred in 123 male and 50 female patients. Positive results for CE-DSE were associated with worse prognosis in both men and women (2-year total event free rate: 73.5% vs 88.2% in men, p<0.0001, 80.3% vs 91.3% in women, p<0.01). Addition of CE-DSE results, including abnormal left ventricular end-systolic volume response and left ventricular ejection fraction at peak stress <50%, to the clinical and rest echocardiography model provided incremental information for predicting total cardiac events (increase in chi-square value for the model from 60 to 72, p<0.001) in men and (increase in chi-square value for the model from 17 to 32, p<0.001) in women. CONCLUSIONS: CE-DSE provides incremental information for predicting future cardiac events in both men and women.
No takes yet. Share an insight, caveat, or question.
Wake et al. (2007) conducted a cohort in Known or suspected coronary artery disease (n=890). Positive results on contrast-enhanced dobutamine stress echocardiography vs. Negative results on contrast-enhanced dobutamine stress echocardiography was evaluated on Total cardiac events (cardiac death, nonfatal myocardial infarction, unstable angina, congestive heart failure, and late revascularization) (HR 2.15, 95% CI 1.48-3.13, p=<0.0001). Positive results on contrast-enhanced dobutamine stress echocardiography independently predicted total cardiac events in both men (HR 2.15) and women (HR 1.77) and provided incremental prognostic information.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: